top of page
Team photo graysacele
Team photo

ZipBio was founded in 2023 by a group of founders with exceptional track records in science, technology and clinical development. Over time, we added more amazing individuals who chose to join our journey.

Our Team

ZipBio was founded in 2023 by a group of founders with successful track records in science, technology, medicine, and drug development. We are constantly adding exceptional individuals who chose to join our journey as core team members, advisors, board members, and investors.

Abstract illustration of compression
A
Roee Farber, M.D

Co-Founder and Chief Executive Officer

B
Abstract illustration of compression
A
Ariel J. Ben-Sasson, Ph.D

Co-Founder and Chief Technology Officer

B
Abstract illustration of compression
A
Ori Hassin, M.D, Ph.D

Co-Founder and Chief Scientific Officer

B
Abstract illustration of compression
A
Ori Zelichov, M.D

Co-Founder and Chief Medical Officer

B
Abstract illustration of compression
A
Gal Masrati, Ph.D

Computational Protein Designer

B
Abstract illustration of compression
A
Ryan Pavlovicz, Ph.D

Computational Protein Designer

B
Abstract illustration of compression
A
Dmitri Zorine, Ph.D

Computational Protein Designer

B
Abstract illustration of compression
A
David Guyer, M.D

Board Member

B
Abstract illustration of compression
A
Omri Amirav Drory, Ph.D

Board Member

B
Abstract illustration of compression
A
Jack Levy, J.D

Board Observer

B
Abstract illustration of compression
A
Siddhartha Jain, Ph.D

Scientific Advisor

B
Abstract illustration of compression
A
Arshad M. Khanani, M.D, MA, FASRS

Scientific Advisor

B
Abstract illustration of compression
A
Mark Pennesi, M.D

Scientific Advisor

B
Abstract illustration of compression
A
Carl Regillo, M.D, FACS

Scientific Advisor

B
Abstract illustration of compression
A
Amy Rosenberg, M.D

Scientific Advisor

B
Abstract illustration of compression
A
David Weinstein, M.D, M.M.Sc

Scientific Advisor

B
Abstract illustration of compression
A
David Williams, Ph.D

Scientific Advisor

B
Our DNA

We are committed to leveraging technology to develop transformative therapies for diseases affecting millions of people worldwide.

Our Partners

We are privileged to work with exceptional investors and business partners who are instrumental in helping us achieve our mission of revolutionizing medicine through AI. Their unwavering support and expertise enable us to push the boundaries of innovation and bring transformative therapies to patients worldwide.

Investors

Business Partners
google cloud logo
bottom of page